Ideal Cures Private Limited - Company Profile

Q: Where is Ideal Cures Private Limited headquartered?

Ideal Cures Private Limited is headquartered at A223 - A229, 2Nd Flr, Virwani Industr Western Express Highway, Goregaon East, Mumbai, Maharashtra, 400063.

Q: Who are the current directors of Ideal Cures Private Limited?

The current directors of Ideal Cures Private Limited are Maulek Jawaharlal Desai, Dinesh Laxminarayan Pandey, Anita Shekhar Dhande.

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1988.

1988 Mumbai, Maharashtra, India Active

Last Updated: March 07, 2026

Access Report

About Ideal Cures Private Limited

Ideal Cures Private Limited, a active private limited company, was established on 18 July 1988 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1988PTC048150. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹10.10 Cr and a paid-up capital of ₹7.50 Cr.

It upholds a compliant status. Employing 241 professional, Its leadership includes Maulek Jawaharlal Desai (Managing Director), Dinesh Laxminarayan Pandey (Company Secretary), Anita Shekhar Dhande (Additional Director). Past directors included Vaishali Manish Tawde, Naveen Wadhera, Dinesh Kumar Pareek. It holds no open charges and ₹6.25 Cr settled loans. Its latest AGM occurred on 23 September 2025, with the balance sheet filed on 31 March 2025. It is based at A/223 - A/229, 2Nd Flr, Virwani Industr Western Express Highway, Goregaon (East), Mumbai, Maharashtra, 400063.

Company Details

CIN/LLPIN
U24239MH1988PTC048150
Registration Number
048150
Incorporation Date
18 July 1988
Authorized Capital
₹10.10 Cr
Paid-Up Capital
₹7.50 Cr
ROC Code
Roc Mumbai I
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 10.10 Cr as on 07-03-2026
Paid Up Capital ₹ 7.50 Cr as on 07-03-2026
Company Age 37 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 6.25 Cr as on 07-03-2026

Comprehensive Company Insights

Explore comprehensive insights into Ideal Cures Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ideal Cures Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Maulek Jawaharlal Desai	Managing Director	01 Apr 2024	Current
Dinesh Laxminarayan Pandey	Company Secretary	01 Nov 2016	Current
Anita Shekhar Dhande	Additional Director	29 Aug 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	13 Jul 2022	Past
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Director	12 Dec 2022	Past
Pramod Abcsdd	Additional Director	13 Oct 2021	Past
Pramod Abcsdd	Additional Director	01 Apr 2024	Past
Pramod Abcsdd	Director	09 Mar 2017	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ideal Cures.

Ideal Cures Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ideal Cures?

In 2023, Ideal Cures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹62,500,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 6.25 Cr

Latest Charge Details

Date	Lender	Amount	Status
28 Jun 2010	Hdfc Bank Limited	₹6.25 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Ideal Cures?

Ideal Cures has a workforce of 241 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ideal Cures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ideal Cures's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ideal Cures

Recent Activity within the Organization

Annual General Meeting

Progress on Ideal Cures Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records. was documented.
23 Sep 2025
Director Appointment

Progress on Anita Shekhar Dhande was appointed as a Additional Director was appointed as a Additional Director on 29 Aug 2025 & has been associated with this company since 7 months 20 days . was documented.
29 Aug 2025
Balance Sheet

Progress on Ideal Cures Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was documented.
31 Mar 2025
Director Appointment

Maulek Jawaharlal Desai was appointed as a Managing Director was appointed as a Managing Director on 01 Apr 2024 & has been associated with this company since 2 years 17 days . was recorded as a recent event.
01 Apr 2024
Director Appointment

The activity Dinesh Laxminarayan Pandey was appointed as a Company Secretary was appointed as a Company Secretary on 01 Nov 2016 & has been associated with this company since 9 years 5 months . was completed.
01 Nov 2016
Director Appointment

Progress on Dinesh Laxminarayan Pandey was appointed as a Company Secretary was appointed as a Company Secretary on 01 Nov 2016 & has been associated with this company since 9 years 5 months . was documented.
01 Nov 2016

Explore recent activity and updates - View Recent Activity